BIOTA SCIENTIFIC MANAGEMENT PTY LTD Patent applications |
Patent application number | Title | Published |
20140179710 | ANTIVIRAL SALTS - This invention relates to antiviral agents, in particular to salts useful in the treatment of infections caused by Picornaviridae, such as human rhinovirus (HRV) and methods for their preparation. The invention also relates to the use of these salts in the treatment of picornavirus infections. The salts of this invention are especially suitable for use in the treatment of HRV, however it is to be understood that the invention is also applicable to other viruses of the picornavirus family. | 06-26-2014 |
20140179709 | ANTIVIRAL AGENTS - This invention relates to compounds of formula I | 06-26-2014 |
20140135332 | AROMATIC AMIDES AND USES THEREOF - The present invention provides compounds of Formula (I): and salts, racemates, isomers, diastereoisomers, enantiomers, hydrates, solvates, N-oxides, pharmaceutically acceptable derivatives or prodrugs thereof. Also provided the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture. | 05-15-2014 |
20140113906 | COMPOUNDS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTIONS - The present invention relates to compounds of formula (I) or salts, racemates, isomers and/or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial viral (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation. | 04-24-2014 |
20140051697 | COMPOUNDS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTIONS - The present invention relates to compounds of formula (I) | 02-20-2014 |
20140051689 | Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections - Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B-C) may be CH | 02-20-2014 |
20140004111 | POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS | 01-02-2014 |
20130274218 | VIRAL POLYMERASE INHIBITORS - The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections. | 10-17-2013 |
20130274179 | VIRAL POLYMERASE INHIBITORS - The present invention relates to viral polymerase inhibitors of formula (I) or salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections. | 10-17-2013 |
20130072520 | ANTIBACTERIAL AGENTS - Compounds of formula (I) have antibacterial activity: | 03-21-2013 |
20130018013 | BICYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS - The present disclosure relates to the use and methods of manufacture of bicyclic nucleosides and nucleotides for the treatment and prevention of infectious and proliferative diseases, including microbial infections and cancer. | 01-17-2013 |
20130005736 | ANTIVIRAL AGENTS - This invention relates to compounds of formula I | 01-03-2013 |
20120122918 | ANTIBACTERIAL AGENTS - Compounds of formula (1) have antibacterial activity: | 05-17-2012 |
20120122811 | BICYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS - The present disclosure relates to the use and methods of manufacture of bicyclic nucleosides and nucleotides for the treatment and prevention of infectious and proliferative diseases, including microbial infections and cancer. | 05-17-2012 |
20120022073 | COMPOUND FOR THE TREATMENT OF ENTEROVIRUSES - The present invention relates to the treatment, alleviation, prevention or reduction in the incidence of symptoms, diseases or conditions resulting from or associated with enteroviruses, more particularly the enteroviral infections they cause. | 01-26-2012 |
20110257192 | COMPOUND FOR TREATMENT OF RESPIRATORY CONDITION OR DISEASE - The present invention relates to the treatment, alleviation, prevention or reduction of symptoms or exacerbations of asthma or chronic obstructive pulmonary disease (COPD), of which reduced lung function is typically symptomatic. | 10-20-2011 |
20110212966 | ANTIVIRAL AGENTS - This invention relates to compounds of formula I | 09-01-2011 |
20110207728 | COMPOUNDS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTIONS - The present invention relates to compounds of formula (I) | 08-25-2011 |
20110144118 | ANTIVIRAL SALTS - This invention relates to antiviral agents, in particular to salts useful in the treatment of infections caused by Picornaviridae, such as human rhinovirus (HRV) and methods for their preparation. The invention also relates to the use of these salts in the treatment of picornavirus infections. The salts of this invention are especially suitable for use in the treatment of HRV, however it is to be understood that the invention is also applicable to other viruses of the picornavirus family. | 06-16-2011 |
20100311684 | NOVEL TRICYCLIC NUCLEOSIDES OR NUCLEOTIDES AS THERAPEUTIC AGENTS - Nucleosides and nucleotides containing a tricyclic base portion thereof are useful for treating infectious diseases and proliferative disorders, such as viral infections or cancer respectively. | 12-09-2010 |
20100291031 | BICYCLIC NUCLEOSIDES AND NUCLEOTIDES AS THERAPEUTIC AGENTS - The invention relates to the use of bicyclic nucleosides and nucleotides based on formula (II) for the treatment of infectious diseases, and in particular, viral infections. | 11-18-2010 |
20090030000 | ANTIVIRAL AGENTS - This invention relates to compounds of formula I | 01-29-2009 |
20090004138 | Bicyclic Nucleosides and Nucleotides as Therapeutic Agents - The invention relates to the use of bicyclic nucleosides and nucleotides based on formula (II) for the treatment of infectious diseases, and in particular, viral infections. | 01-01-2009 |